Espinosa, Rinelyn H.
HRN: 25-18-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2024
AMPICILLIN 1GM (VIAL)
06/12/2024
06/18/2024
IV
2g
Q6
PROM Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes